the agilent technologies ( gaa ) team delivered a strong start to 2020. the growth and profitability of our business are consistent with expectations. the growth of our business is broad - based and is driven by strong growth in the biopharma and environmental forensics markets. we continue to translate our topline growth into strong bottomline earnings. our shareholder value creation model is at the high-end of our guidance.